Integrated Filing — IndAS



General information about company

Scrip Code 543593
NSE Symbol DBOL
MSEI Symbol NA
ISIN INE0I3401014
Name of company Dhampur Bio Organics Limited
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 30-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 25-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 30-05-2026   11:10:00
End date and time of board meeting 30-05-2026   11:45:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 77,359.00 3,13,341.00
Other income 782.00 3,183.00
Total income 78,141.00 3,16,524.00
2 Expenses
(a) Cost of materials consumed 75,226.00 1,47,517.00
(b) Purchases of stock-in-trade 104.00 4,127.00
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (42,111.00) 8,190.00
(d) Employee benefit expense 3,199.00 11,342.00
(e) Finance costs 1,647.00 6,298.00
(f) Depreciation, depletion and amortisation expense 1,467.00 5,881.00
(f) Other Expenses
1 Excise duty on sale of goods 23,389.00 1,02,416.00
2 Other Expenses 8,062.00 26,663.00
Total other expenses 31,451.00 1,29,079.00
Total expenses 70,983.00 3,12,434.00
3 Total profit before exceptional items and tax 7,158.00 4,090.00
4 Exceptional items 0.00 0.00
5 Total profit before tax 7,158.00 4,090.00
6 Tax expense
7 Current tax 599.00 647.00
8 Deferred tax 1,932.00 925.00
9 Total tax expenses 2,531.00 1,572.00
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 4,627.00 2,518.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method 0.00 0.00
16 Total profit (loss) for period 4,627.00 2,518.00
17 Other comprehensive income net of taxes 304.00 266.00
18 Total Comprehensive Income for the period 4,931.00 2,784.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 4,627.00 2,518.00
Total profit or loss, attributable to non-controlling interests 0.00 0.00
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 4,931.00 2,784.00
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 6,639.00 6,639.00
Face value of equity share capital 10 10
27 Details of debt securities
22 Reserves excluding revaluation reserve 96,025.00
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 7.01 3.81
Diluted earnings (loss) per share from continuing operations 6.98 3.8
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 7.01 3.81
Diluted earnings (loss) per share from continuing and discontinued operations 6.98 3.8
24 Debt equity ratio
25 Debt service coverage ratio
26 Interest service coverage ratio
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) 1. These audited consolidated financial results which are published in accordance with Regulation 33 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('Listing Regulations’) have been reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on May 30, 2026. These audited consolidated financial results have been prepared in accordance with recognition and measurement principles of Indian Accounting Standards (Ind-AS) prescribed under Section 133 of the Companies Act, 2013, read with the relevant rules issued thereunder and the other accounting principles generally accepted in India. 2. The figures for the quarter ended March 31, 2026 are the balancing figures between the audited figures in respect of the full financial year and the published unaudited year to date figures up to the third quarter of the financial year. 3. The Parent Company has two wholly owned subsidiaries, Sonitron Bio Organics Private Limited & Dhampur International Pte. Limited as on March 31, 2026. 4. Pursuant to the resolution passed by the shareholders of the Parent Company dated May 4, 2025 via Postal Ballot wherein DBO Employee Stock Option Scheme 2025 was approved, during the quarter ended September 30, 2025, the Parent Company granted 357881 stock options convertibles into equal number of equity shares of the Parent Company of face value of Rs. 10 each, as approved by the Nomination and Remuneration Committee (NRC) of the Parent Company, to the eligible employees of the Parent Company, through Trust route, under the DBO Employee Stock Option Scheme 2025. The Parent Company has granted interest free loan to the DBO Employee Welfare Trust (Trust) amounting to Rs. 5.50 Crores (Rupees Five Crore Fifity Lakhs only) and the Trust has acquired 599000 shares from the market at an average price of Rs. 86.01 per share. Acquisition cost of shares held by the Trust is presented as reduction in ‘Other Equity’. Share based payment expense for the quarter and year ended March 31, 2026 is Rs. 0.10 Crore and Rs. 0.28 Crore respectively. 5. Other income for the quarter and year ended March 31, 2026 includes insurance claims of Rs. 4.05 Crore and Rs. 21.97 Crore respectively, equivalent to the loss/expenditure incurred due to break downs and accidents during the period respectively, which are accounted for as per consistant accounting policy followed by the Parent Company. 6. Pursuant to the implementation of the New Labour Codes with effect from November 21, 2025 (the supporting Rules are yet to be notified), the Parent Company has determined and recognised defined benefit obligations during the quarter ended March 31, 2026 as estimated by actuarial based on revised wage definition. The impact of the same is not material. Parent Company is in the process of evaluating other possible impacts, if any. However, management is of the view that such impact, if any, is unlikely to be material. 7. During the current year, the Income Tax Department (the Department) has conducted a search under Section 132 of the Income Tax Act, 1961 at the head office and other premises of the Parent Company from October 29, 2025 to November 04, 2025. The Parent Company has provided necessary support, co-operation and documents as requested by the Department during the search and seizure operation. While the uncertainty exists regarding the outcome of the search and seizure carried out by the Department, the Parent Company after considering all available information and facts as of date, has not identified the need for any adjustments in these financial results. 8. Subsequent to the reporting date, the Parent Company entered into a Business Transfer Agreement (BTA) on April 20, 2026 for transfer of the one of its sugar manufacturing undertaking comprising sugar and co-generation plant located at Meerganj, Bareilly, Uttar Pradesh, (“Meerganj Unit”) on slump sale basis for an aggregate consideration of Rs. 305.00 Crores which has also been approved by the shareholders in the EGM held on May 18, 2026. The sale is expected to be completed within 60 days from the date of execution of the BTA which may be extended as per mutual agreement between the Parent Company and the Buyer in accordance with the terms of the BTA. 9. The Board of Directors of the Parent Company at its meeting held on May 30, 2026 recommanded final dividend of 15% (i.e. Rs.1.50 per share on face value of Rs. 10 per share) amounting to Rs. 9.96 Crores. 10. Sugar being a seasonal industry, the performance of the quarter may not be representative of the annual performance of the Group. 11. Figures for the previous corresponding periods have been regrouped, wherever considered necessary. 12. The audited standalone financial results are available on the website of the Company (www.Dhampur.com). The specified items of the standalone audited financial results of the Company are given below: Quarter ended Year ended Particualrs 31-Mar-26 31-Dec-25 31-Mar-25 31-Mar-26 31-Mar-25 Total Income 793.45 714.21 703.57 3137.14 2718.11 Profit before tax 71.32 21.49 60.27 40.29 17.84 Profit after tax 46.00 13.87 39.65 24.97 12.09



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 1,12,469.00
Capital work-in-progress 98.00
Investment property
Goodwill 8.00
Other intangible assets 591.00
Intangible assets under development
Biological assets other than bearer plants
Investments accounted for using equity method
Non-current financial assets
Non-current investments 237.00
Trade receivables, non-current
Loans, non-current 0.00
Other non-current financial assets
1 Other non-current financial assets 278.00
Total of other non-current financial assets 278.00
Total non-current financial assets 515.00
Deferred tax assets (net)
Other non-current assets
1 Other non-current assets 630.00
Total of other non-current assets 630.00
Total non-current assets 1,14,311.00
2 Current assets
Inventories 1,01,317.00
Current financial asset
Current investments 0.00
Trade receivables, current 6,378.00
Cash and cash equivalents 871.00
Bank balance other than cash and cash equivalents 2,745.00
Loans, current 0.00
Other current financial assets
Total of other current financial assets 102.00
Total current financial assets 10,096.00
Current tax assets (net) 271.00
Other current assets
1 Other current assets 6,152.00
2 Assets Held for disposal 66.00
Total of other current assets 6,218.00
Total current assets 1,17,902.00
3 Non-current assets classified as held for sale
4 Regulatory deferral account debit balances and related deferred tax Assets
Total assets 2,32,213.00
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 6,639.00
Other equity 96,025.00
Total equity attributable to owners of parent 1,02,664.00
Non controlling interest 0.00
Total equity 1,02,664.00
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 20,698.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Lease Liabilities 273.00
2 Other non-current financial liabilities 100.00
Total of other non-current financial liabilities 373.00
Total non-current financial liabilities 21,071.00
Provisions, non-current 2,353.00
Deferred tax liabilities (net) 4,893.00
Deferred government grants, Non-current
Other non-current liabilities
1 Other non-current liabilities 9.00
Total of other non-current liabilities 9.00
Total non-current liabilities 28,326.00
Current liabilities
Current financial liabilities
Borrowings, current 84,719.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 1,541.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 9,964.00
Total Trade payable 11,505.00
Other current financial liabilities
1 Lease Liabilities 356.00
2 Other current financial liabilities 2,652.00
Total of other current financial liabilities 3,008.00
Total current financial liabilities 99,232.00
Other current liabilities 1,624.00
1 Other current liabilities 1,624.00
Total of other current liabilities 1,624.00
Provisions, current 367.00
Current tax liabilities (Net)
Deferred government grants, Current
Total current liabilities 1,01,223.00
3 Liabilities directly associated with assets in disposal group classified as held for sale
4 Regulatory deferral account credit balances and related deferred tax liability
Total liabilities 1,29,549.00
Total equity and liabilites 2,32,213.00
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Sugar 48,350.00 1,84,322.00
2 Bio Fuels & Spirits 9,441.00 40,063.00
3 Country Liquor 25,978.00 1,13,641.00
Total Segment Revenue 83,769.00 3,38,026.00
Less: Inter segment revenue 6,410.00 24,685.00
Revenue from operations 77,359.00 3,13,341.00
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Sugar 9,129.00 13,129.00
2 Bio Fuels & Spirits 956.00 839.00
3 Country Liquor 304.00 1,675.00
Total Profit before tax 10,389.00 15,643.00
i. Finance cost 1,647.00 6,298.00
ii. Other Unallocable Expenditure net off Unallocable income 1,584.00 5,255.00
Profit before tax 7,158.00 4,090.00
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Sugar 1,81,700.00 1,81,700.00
2 Bio Fuels & Spirits 36,228.00 36,228.00
3 Country Liquor 7,512.00 7,512.00
Total Segment Asset 2,25,440.00 2,25,440.00
Un-allocable Assets 6,773.00 6,773.00
Net Segment Asset 2,32,213.00 2,32,213.00
4 Segment Liabilities
Segment Liabilities
1 Sugar 15,547.00 15,547.00
2 Bio Fuels & Spirits 1,048.00 1,048.00
3 Country Liquor 1,756.00 1,756.00
Total Segment Liabilities 18,351.00 18,351.00
Un-allocable Liabilities 1,11,198.00 1,11,198.00
Net Segment Liabilities 1,29,549.00 1,29,549.00
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Remeasurement benefits (losses) on defined benefit obligation 224.00 6.00
Total Amount of items that will not be reclassified to profit and loss 224.00 6.00
2 Income tax relating to items that will not be reclassified to profit or loss 57.00 2.00
3 Amount of items that will be reclassified to profit and loss
1 Foreign Currency Translation Reserve 137.00 262.00
Total Amount of items that will be reclassified to profit and loss 137.00 262.00
4 Income tax relating to items that will be reclassified to profit or loss 0.00 0.00
5 Total Other comprehensive income 304.00 266.00



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 4,090.00
Adjustments for reconcile profit (loss)
Adjustments for finance costs 6,298.00
Adjustments for decrease (increase) in inventories 8,115.00
Adjustments for decrease (increase) in trade receivables, current (871.00)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets (2,592.00)
Adjustments for decrease (increase) in other non-current assets 0.00
Adjustments for other financial assets, non-current 9.00
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current 900.00
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities (61.00)
Adjustments for increase (decrease) in other non-current liabilities 0.00
Adjustments for depreciation and amortisation expense 5,881.00
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0.00
Adjustments for provisions, current (88.00)
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 410.00
Adjustments for other financial liabilities, non-current 0.00
Adjustments for unrealised foreign exchange losses gains 262.00
Adjustments for dividend income 0.00
Adjustments for interest income 172.00
Adjustments for share-based payments 28.00
Adjustments for fair value losses (gains) 0.00
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items (381.00)
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) 17,738.00
Net cash flows from (used in) operations 21,828.00
Dividends received 0.00
Interest paid 0.00
Interest received 0.00
Income taxes paid (refund) (158.00)
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities 21,986.00
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0.00
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0.00
Proceeds from sales of property, plant and equipment 196.00
Purchase of property, plant and equipment 4,435.00
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 0.00
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 237.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 66.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 256.00
Net cash flows from (used in) investing activities (4,154.00)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 514.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 6,000.00
Repayments of borrowings 15,813.00
Payments of lease liabilities 563.00
Dividends paid 830.00
Interest paid 6,129.00
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (17,849.00)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (17.00)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0.00
Net increase (decrease) in cash and cash equivalents (17.00)
Cash and cash equivalents cash flow statement at beginning of period 888.00
Cash and cash equivalents cash flow statement at end of period 871.00





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/s. Mittal Gupta & Co. Yes 29-02-2028